Myelodysplastic syndrome surgery: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
No edit summary |
||
| (10 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Myelodysplastic syndrome}} | {{Myelodysplastic syndrome}} | ||
{{CMG}}; {{AE}} {{NM}} | {{CMG}}; {{AE}} {{NM}} {{ADS}} | ||
==Overview== | ==Overview== | ||
Surgery is not the first-line treatment option for patients with myelodysplastic syndrome. Stem cell transplantation is usually reserved for patients who are either young or those with high-risk myelodysplastic syndrome. | |||
==Surgery== | ==Surgery== | ||
===Stem | ===Stem Cell Transplantation=== | ||
* A stem cell transplant may be a treatment option for:<ref name="cancerca">Treatment of myelodysplastic syndrome. National Cancer Institute (2018). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 7, 2018</ref> | |||
** Younger patients | |||
** High-risk myelodysplastic syndrome | |||
==References== | ==References== | ||
{{reflist| | {{reflist|1}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 16: | Line 19: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 21:15, 7 December 2018
|
Myelodysplastic syndrome Microchapters |
|
Differentiating Myelodysplastic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myelodysplastic syndrome surgery On the Web |
|
American Roentgen Ray Society Images of Myelodysplastic syndrome surgery |
|
Risk calculators and risk factors for Myelodysplastic syndrome surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2] Amandeep Singh M.D.[3]
Overview
Surgery is not the first-line treatment option for patients with myelodysplastic syndrome. Stem cell transplantation is usually reserved for patients who are either young or those with high-risk myelodysplastic syndrome.
Surgery
Stem Cell Transplantation
- A stem cell transplant may be a treatment option for:[1]
- Younger patients
- High-risk myelodysplastic syndrome
References
- ↑ Treatment of myelodysplastic syndrome. National Cancer Institute (2018). http://www.cancer.ca/en/cancer-information/cancer-type/leukemia/leukemia/myelodysplastic-syndromes/?region=on. Accessed on December 7, 2018